Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) stock price and financial data

Issuer profile

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) is an Egypt-based pharmaceuticals business in the healthcare sector, listed on the Egyptian Exchange under ticker RMDA.CA. 10th of Ramadan for Pharmaceutical and Diagnostic Reagents Co SAE is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals. It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others. Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) owns an extensive product portfolio covering anti-infective, anti-diabetic, respiratory, ophthalmology, gastro-intestinal tract, cardio-vascular, central nervous system, vitamins and analgesics. Additionally, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (SAE) provides contract manufacturing services to a number of local and multinational pharmaceutical companies. Its investment profile is best assessed through product quality, regulatory compliance, distribution, pricing, and demand from Egypt’s healthcare market. Key analysis points include business model clarity, durability of revenue sources, cost control, cash conversion, leverage, shareholder structure, and the consistency of public disclosures over time.